CUI JINGRONG JEAN (Chief Scientific Officer) sold 4.9% of their position (48.50K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.95M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−3.73K
Price / share
$57.76
Trade value
$215.44K
% of position
Common Stock
Shares
−3.90K
Price / share
$58.48
Trade value
$227.96K
% of position
Common Stock
Shares
−7.80K
Price / share
$59.78
Trade value
$466.40K
% of position
Common Stock
Shares
−3.07K
Price / share
$60.38
Trade value
$185.37K
% of position
Common Stock
Shares
−1.40K
Price / share
$59.84
Trade value
$83.78K
% of position
Common Stock
Shares
−9.23K
Price / share
$60.69
Trade value
$560.17K
% of position
Common Stock
Shares
−4.97K
Price / share
$61.48
Trade value
$305.56K
% of position
Common Stock
Shares
−2.90K
Price / share
$62.33
Trade value
$180.76K
% of position
Common Stock
Shares
−1.40K
Price / share
$62.64
Trade value
$87.70K
% of position
Common Stock
Shares
−8.50K
Price / share
$63.42
Trade value
$539.07K
% of position
Common Stock
Shares
−1.60K
Price / share
$63.99
Trade value
$102.38K
% of position
Net shares
−48.50K
Net value
-$2.95M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/18/2019 | S · Sale | −3.73K | $57.76 | $215.44K | 0.4% | 984.72K | 980.99K |
| Common Stock Indirect | 12/18/2019 | S · Sale | −3.90K | $58.48 | $227.96K | 0.4% | 980.99K | 977.09K |
| Common Stock Indirect | 12/18/2019 | S · Sale | −7.80K | $59.78 | $466.40K | 0.8% | 977.09K | 969.29K |
| Common Stock Indirect | 12/18/2019 | S · Sale | −3.07K | $60.38 | $185.37K | 0.3% | 969.29K | 966.22K |
| Common Stock Indirect | 12/19/2019 | S · Sale | −1.40K | $59.84 | $83.78K | 0.1% | 966.22K | 964.82K |
| Common Stock Indirect | 12/19/2019 | S · Sale | −9.23K | $60.69 | $560.17K | 1.0% | 964.82K | 955.59K |
| Common Stock Indirect | 12/19/2019 | S · Sale | −4.97K | $61.48 | $305.56K | 0.5% | 955.59K | 950.62K |
| Common Stock Indirect | 12/19/2019 | S · Sale | −2.90K | $62.33 | $180.76K | 0.3% | 950.62K | 947.72K |
| Common Stock Indirect | 12/20/2019 | S · Sale | −1.40K | $62.64 | $87.70K | 0.1% | 947.72K | 946.32K |
| Common Stock Indirect | 12/20/2019 | S · Sale | −8.50K | $63.42 | $539.07K | 0.9% | 946.32K | 937.82K |
| Common Stock Indirect | 12/20/2019 | S · Sale | −1.60K | $63.99 | $102.38K | 0.2% | 937.82K | 936.22K |
| Total | −48.50K | -$2.95M | ||||||
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.30M | Direct |
| Total | 1.30M | 1.30M direct |